1. Dr Reddy’s launches generic hepatitis C drug in India

Dr Reddy’s launches generic hepatitis C drug in India

Dr Reddy's Laboratories today said it has launched a generic version of Sofosbuvir 400 mg and Velpatasvir 100 mg fixed-dose combination, indicated for the treatment of chronic hepatitis C, in the country.

By: | Published: May 15, 2017 5:16 PM
The Hyderabad-based firm has launched its generic product under the brand name Resof Total, Dr Reddy’s Laboratories said in a statement.

Dr Reddy’s Laboratories today said it has launched a generic version of Sofosbuvir 400 mg and Velpatasvir 100 mg fixed-dose combination, indicated for the treatment of chronic hepatitis C, in the country. The Hyderabad-based firm has launched its generic product under the brand name Resof Total, Dr Reddy’s Laboratories said in a statement.

Dr Reddy’s product is a generic version of Gilead’s brand Epclusa. “Treatment with this combination achieves a cure rate of more than 90 per cent in all genotypes of Hepatitis C virus,” the company said.

Shares of the company ended 3.54 per cent up at Rs 2,676.15 on BSE.

Get latest news and updates on Auto Expo 2018, check breaking news on Budget 2018, like us on Facebook and follow us on Twitter.

  1. No Comments.

Go to Top